Development and evaluation of carbomer based matrices for the controlled delivery of diclofenac sodium

Acta Pharmaceutica Turcica

Volumn 45, Issue 1, 2003, Pages 5-10

  Rani, Meena ^a   Mishra, B ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Carbomer based matrices; Diclofenac sodium; NSAID; Oral drug delivery; Zero order drug delivery

Indexed keywords

CARBOMER; CARBOPOL 974P; CARBOXYMETHYLCELLULOSE; DICLOFENAC; HYDROXYPROPYLMETHYLCELLULOSE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED DRUG RELEASE; DRUG MANUFACTURE; KINETICS; OSTEOARTHRITIS; PERFORMANCE; RHEUMATOID ARTHRITIS; WEIGHT;

EID: 0038014102     PISSN: 1300638X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ahuja, A., Khar, R.K. and Ali, J. (1997). Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. 23: 489-515.
2. Durrani, M. J., Andrews, A., Whitaker, R. and Benner, S.C. (1994). Studies on drug release kinetics from carbomer matrices. Drug Dev. Ind. Pharm. 20: 2439-2447.
3. Fassihi, A.R. and Parker, M.S. (1986). Controlled drug release from a compressed heterogeneous polymeric matrix: kinetics of release. Drug Dev. Ind. Pharm. 12: 1649-1661.
4. Gohel, M.C. and Amin, A.F. (1999). Formulation design and optimisation of modified release microspheres of diclofenac sodium. Drug Dev. Ind. Pharm. 25: 247-251.
5. Hasan, M., Najib, N., Suleiman, M., El-Sayed, Y. and Abdul-Hamid, M. (1992). In-vitro and in-vivo evaluation of sustained release and enteric coated microcapsules of diclofenac sodium. Drug Dev. Ind. Pharm. 18: 1981-1988.
6. Hosny, E.A., Al-Helw, A.R.M. and Al-Dardiri, M.A. (1997). Comparative study of in-vitro release and bioavailability of sustained release diclofenac sodium from certain hydrophillic polymers and commercial tablets in beagle dogs. Pharm. Acta. Helv. 72: 159-164.
7. Malamataris, S. and Ganderton, D. (1991). Sustained release from matrix system comprising hydrophobic and hydrophilic (gel forming) parts. Int. J. Pharm. 70: 69-75.
8. Matharu, R.S. and Sanghavi, N.M. (1992). Novel drug delivery system for captopril. Drug Dev. Ind. Pharm. 18: 1567-1574.
9. Mishra, B., Panyam, J. and Sharma, A.V. (1999a). In-vitro release of diclofenac sodium from multiple emulsions: Effect of location of drug and pH of the aqueous phase. Acta Pharm. Turc. 41: 42-45.
10. Mishra, B., Panyam, J. and Sharma, A.V. (1999b). Mechanism of drug release control by osmotic additives from multiple emulsions containing diclofenac sodium. Acta Pharm. Turc. 41: 58-61.
11. Nishihata, T. (1987). Simple formulation of sustained-release tablets of sodium diclofenac and examination in humans. Int. J. Pharm. 40: 125-128.
12. Nokhodchi, A., Farid, Dj., Najafi, M. and Adrangui, M. (1997). Studies on controlled-release formulations of diclofenac sodium. Drug Dev. Ind. Pharm. 23: 1019-1023.
13. Peppas, N.A. and Franson, N.M. (1983). The swelling interface number as a criterion for prediction of diffusional solute release mechanisms in swellable polymers. J. Polym. Sci. 21, 983-997.
14. Ranga Rao, K.V., Devi, P.K. and Buri, P. (1990). Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J. Contrl. Rel. 12: 133-141.
15. Sankar, C., Rani, M., Srivastava, A.K. and Mishra, B. (2001). Chitosan based pentazocine microspheres for intranasal systemic delivery-development and biopharmaceutical evaluation. Pharmazie 56: 223-226.
16. Todd, A. and Sorkin, E.M. (1988). Diclofenac sodium, a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 35: 244-285.
17. Traconis, N., Rodriguez, R., Campo, M.E. and Villafuerte, L. (1997). Influence of admixed polymers on the metronidazole release from hydroxypropylmethylcellulose matrix tablets. Pharm. Acta Helv. 72: 131-138.
18. st Rev., United States Pharmacopoeial Convention, Inc. Rockville, pp. 1277.